Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 1;21(4):378-386.
doi: 10.1093/ehjci/jez277.

Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study

Diego Segura-Rodríguez  1   2 , Francisco José Bermúdez-Jiménez  1   2 , Víctor Carriel  2   3 , Silvia López-Fernández  1   2 , Mercedes González-Molina  1   2 , José Manuel Oyonarte Ramírez  1   2 , Laura Fernández-Navarro  4 , María Dolores García-Roa  4 , Elisa M Cabrerizo  5 , Daniel Durand-Herrera  2   3 , Miguel Alaminos  2   3 , Antonio Campos  2   3 , Rosa Macías  1   2 , Miguel Álvarez  1   2 , Luis Tercedor  1   2 , Juan Jiménez-Jáimez  1   2
Affiliations
Free article

Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study

Diego Segura-Rodríguez et al. Eur Heart J Cardiovasc Imaging. .
Free article

Abstract

Aims: Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a life-threatening entity with a highly heterogeneous genetic background. Cardiac magnetic resonance (CMR) imaging can identify fibrofatty scar by late gadolinium enhancement (LGE). Our aim is to investigate genotype-phenotype correlation in ARVC/D mutation carriers, focusing on CMR-LGE and myocardial fibrosis patterns.

Methods and results: A cohort of 44 genotyped patients, 33 with definite and 11 with borderline ARVC/D diagnosis, was characterized using CMR and divided into groups according to their genetic condition (desmosomal, non-desmosomal mutation, or negative). We collected information on cardiac volumes and function, as well as LGE pattern and extension. In addition, available ventricular myocardium samples from patients with pathogenic gene mutations were histopathologically analysed. Half of the patients were women, with a mean age of 41.6 ± 17.5 years. Next-generation sequencing identified a potential pathogenic mutation in 71.4% of the probands. The phenotype varied according to genetic status, with non-desmosomal male patients showing lower left ventricular (LV) systolic function. LV fibrosis was similar between groups, but distribution in non-desmosomal patients was frequently located at the posterolateral LV wall; a characteristic LV subepicardial circumferential LGE pattern was significantly associated with ARVC/D caused by desmin mutation. Histological analysis showed increased fibrillar connective tissue and intercellular space in all the samples.

Conclusion: Desmosomal and non-desmosomal mutation carriers showed different morphofunctional features but similar LV LGE presence. DES mutation carriers can be identified by a specific and extensive LV subepicardial circumferential LGE pattern. Further studies should investigate the specificity of LGE in ARVC/D.

Keywords: arrhythmogenic cardiomyopathy; cardiac magnetic resonance; desmin; histology; late gadolinium enhancement; myocardial fibrosis.

PubMed Disclaimer

Comment in

Publication types